Sinovac's combined hepatitis A and B vaccine, Beirlaifu, is re-registered for market launch

Beijing Kexing Holdings Co., Ltd. subsidiary Beijing Kexing Biological Products Co., Ltd. independently developed the combined hepatitis A and B vaccine Beirlaifu, which has obtained the drug re-registration approval notice, making it the only combined hepatitis A and B vaccine approved for sale in China